IFNAR1 and infection: Consistent with our screen and in contrast to the observations with separate cultures, we found that IFNAR1-disrupted cells in this context exhibited a significant competitive advantage over control cells during SARS-CoV-2 infection but not during mock infection (Fig. 2F and G; Fig. S5).